The neurodegenerative disease damages patients' motor, cognitive and behavioral controls, which sometimes manifest as ...

As well as slowing disease progression by 75 percent at 36 months, the scientists found that neurofilament light protein (NfL ...

The landscape of treating Huntington's disease, a cruel and relentless neurological disorder, may be on the verge of a revolutionary shift. For a disease that has long defied efforts to slow its ...

After years of heartbreak, researchers have found an experimental treatment that can slow the progression of Huntington’s ...

A one-time gene therapy called AMT-130 helped slow the progression of Huntington's disease by 75%, paving the way for the ...

Huntington's disease is a fatal, hereditary neurological disorder mostly striking people between the ages of 30 and 50.

Topline data were announced from a pivotal phase 1/2 study evaluating AMT-130 in patients with Huntington disease.

BUFFALO, N.Y. — A decade ago, University at Buffalo researchers shed some light on an enduring neuroscience mystery: How exactly does a mutated huntingtin protein (HTT) cause Huntington’s disease?

Huntington's Disease is a fatal genetic disease that breaks down the mind and body, and there is no cure. About 41,000 people live with this debilitating disease. Next Saturday you can join families ...

Were you Seen at the 2025 Corks & Forks event benefiting the Huntington's Disease Society of America on March 28, 2025, at Duo at the Dunes in Albany? Empire Wine hosted the event. Were you Seen at ...